• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    US Blood Pressure Test Market

    ID: MRFR/LS/14181-HCR
    100 Pages
    Garvit Vyas
    October 2025

    US Blood Pressure Test Market Research Report By Product (sphygmomanometers, blood pressure transducers, instrument accessories), By Indication (hypertension, coronary heart disease) and By End User (hospital, clinic, diagnostic center) - Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    US Blood Pressure Test Market Infographic
    Purchase Options

    US Blood Pressure Test Market Summary

    The United States blood pressure test market is projected to grow significantly from 480 USD million in 2024 to 1170 USD million by 2035.

    Key Market Trends & Highlights

    US Blood Pressure Test Key Trends and Highlights

    • The market is expected to expand at a compound annual growth rate (CAGR) of 8.44 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 1170 USD million, indicating robust growth potential.
    • In 2024, the market is valued at 480 USD million, reflecting a solid foundation for future expansion.
    • Growing adoption of advanced monitoring technologies due to increasing awareness of hypertension is a major market driver.

    Market Size & Forecast

    2024 Market Size 480 (USD Million)
    2035 Market Size 1170 (USD Million)
    CAGR (2025-2035) 8.44%

    Major Players

    Omron Healthcare, HillRom Holdings, Roche Diagnostics, Takeda Pharmaceutical, Medtronic, Abbott Laboratories, Baxter International, Welch Allyn, Microlife Corporation, A and D Medical, Cardinal Health, GE Healthcare, Philips Healthcare

    US Blood Pressure Test Market Trends

    The US Blood Pressure Test Market is experiencing significant growth driven by an increasing prevalence of hypertension and cardiovascular diseases among the population. Approximately 45% of adults in the US have hypertension, which heightens the demand for regular monitoring and testing. This trend is further supported by rising health awareness and proactive health management among consumers, leading to greater adoption of personal health devices, including home blood pressure monitors. There are numerous opportunities to be explored within the market. Telehealth services are becoming more integrated, allowing patients to consult with healthcare providers remotely while using connected blood pressure monitoring devices.

    This offers a convenient way for patients to engage in their care and helps manage their conditions effectively. Additionally, initiatives by government health organizations encourage routine blood pressure screenings, which can enhance market penetration by promoting awareness and accessibility. In recent times, the market has seen a notable shift toward innovative technology such as the development of digital blood pressure monitors that provide data analytics and connectivity options to mobile apps. This change aligns with the growing trend of digital health solutions, allowing users to track their blood pressure trends over time conveniently.

    Furthermore, the trend of personalized medicine is influencing blood pressure testing, where devices are designed to cater to individual patient requirements. Overall, the ongoing technological advancements, combined with a supportive regulatory environment focused on reducing the burden of hypertension, underscore the vibrant growth potentials within the US Blood Pressure Test Market.

    Market Segment Insights

    Blood Pressure Test Market Product Insights

    The US Blood Pressure Test Market is witnessing significant growth driven by the increasing prevalence of hypertension and related cardiovascular diseases among the population. The Product segment is a crucial area within this market, comprising various key components that facilitate blood pressure monitoring. Sphygmomanometers play a vital role in traditional blood pressure measurement; their reliability and accuracy make them a preferred choice among healthcare professionals. This instrument is essential for clinical assessments and is frequently used in hospitals, clinics, and home care settings.

    Blood pressure transducers, which convert pressure into an electrical signal, are becoming increasingly important in modern diagnostic settings due to their ability to provide continuous and accurate readings, thus enhancing patient monitoring. Instrument accessories, which support and enhance the functionality of blood pressure measurement devices, are often overlooked yet play a significant role in providing comprehensive care. These accessories include cuffs, hoses, and adapters that ensure proper device utilization. The growing focus on preventive healthcare and remote patient monitoring is anticipated to drive innovation in these Product segments, facilitating enhanced accuracy and efficiency in blood pressure management.

    As the US healthcare system adapts to changing patient needs, the relevance of these Products in offering reliable hypertension management solutions is continually underscored. Furthermore, the aging population in the United States is a critical factor contributing to the expansion of the blood pressure testing market, as older adults are more prone to blood pressure-related health issues, thereby increasing the demand for these essential diagnostic tools. Overall, this Product segment within the US Blood Pressure Test Market represents a significant opportunity for advancement and improvement in hypertension detection and management, ultimately contributing to better health outcomes for the population.

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    Blood Pressure Test Market Indication Insights

    The US Blood Pressure Test Market, particularly within the Indication segment, encompasses critical health conditions such as hypertension and coronary heart disease, both of which significantly impact public health. Hypertension, often termed the silent killer, affects millions of Americans and is a key driver for regular blood pressure monitoring. The integration of advanced testing technologies has improved early detection and management, essential for reducing complications associated with this condition. Coronary heart disease, a leading cause of mortality in the U.S., also underscores the necessity of routine blood pressure tests, as high blood pressure is a major risk factor.

    The emphasis on preventative care in the healthcare system promotes increased demand for blood pressure tests, aligning with national health objectives aimed at reducing cardiovascular morbidity and mortality. Both indications represent vital areas for market growth, fueled by rising awareness, better diagnostics technology, and a growing aging population, further reinforcing the critical role of blood pressure testing in the healthcare continuum. The continuous focus on managing these conditions indicates a robust opportunity for advancements in blood pressure test technologies and methodology.

    Blood Pressure Test Market End User Insights

    The US Blood Pressure Test Market is significantly influenced by its End User category, which includes various healthcare settings such as hospitals, clinics, and diagnostic centers. Hospitals represent a critical portion of this market, as they are often the first point of contact for patients requiring blood pressure assessments, facilitated by emergency care and inpatient monitoring. Clinics serve an essential role in providing routine check-ups and chronic disease management, making them vital for early detection and proactive care, thus supporting the overall healthcare system in managing hypertension effectively.

    Diagnostic centers, specializing in providing specific tests, contribute to developing precise blood pressure monitoring solutions; they allow for specialized testing environments that enhance accuracy and reliability in results.

    The increasing awareness of cardiovascular diseases coupled with a rise in health-conscious populations drives demand across these segments. Additionally, advancements in technology and telehealth services present opportunities to improve patient care, ensuring more accessible, efficient blood pressure monitoring. As the market continues to evolve, ensuring quality results in these settings remains a primary focus, supporting the growth and innovation of the US Blood Pressure Test Market.

    Get more detailed insights about US Blood Pressure Test Market

    Key Players and Competitive Insights

    The US Blood Pressure Test Market is a dynamic sector reflecting the increasing awareness around cardiovascular health and the need for early detection of hypertension. With the growing prevalence of lifestyle-related diseases, the demand for blood pressure monitoring devices has surged. The market is characterized by a mix of technologically advanced products and traditional devices, catering to both home users and healthcare providers.

    Competitive insights within this market reveal a landscape where innovation and customer engagement are key differentiators, with many companies investing in smart technology, remote monitoring capabilities, and user-friendly designs to capture a larger share of the growing population concerned about blood pressure management.

    The competitive dynamics are further influenced by regulatory approvals, reimbursement policies, and consumer preferences towards more advanced and convenient health monitoring solutions. Omron Healthcare has established a robust presence in the US Blood Pressure Test Market, distinguished by its wide range of clinically validated devices. The company is known for its commitment to innovation, having developed advanced blood pressure monitors that feature Bluetooth connectivity to sync with mobile applications for better health tracking. As a pioneer in home healthcare technology, Omron Healthcare emphasizes accuracy and ease of use, appealing to both consumers and healthcare professionals.

    Their strength lies in their established brand reputation, significant market penetration, and a vast distribution network that encompasses online and retail channels. Furthermore, the company often engages in educational initiatives to promote awareness about hypertension, enhancing customer loyalty and trust in their products.

    HillRom Holdings, operating within the US Blood Pressure Test Market, focuses on delivering high-quality health solutions that cater to the needs of healthcare providers. The company is recognized for its innovative blood pressure monitoring systems integrated with digital health solutions aimed at improving patient care and clinical efficiency. HillRom's strengths lie in their comprehensive portfolio of medical devices, including advanced patient monitoring systems and software that allow for real-time data collection. Their commitment to innovation is strengthened through strategic partnerships and collaborations, enhancing their technology capabilities.

    Mergers and acquisitions have also played a significant role in bolstering HillRom’s market position, enabling them to expand their product offerings and enhance their service capabilities tailored to the US market. HillRom’s focus on addressing critical care challenges and delivering integrated solutions uniquely positions them to succeed in the competitive landscape of the blood pressure test market.

    Key Companies in the US Blood Pressure Test Market market include

    Industry Developments

    The US Blood Pressure Test Market has seen significant advancements recently, particularly in advancing diagnostic technologies and patient monitoring solutions. Notable developments include Omron Healthcare’s introduction of new innovative devices aimed at promoting home-based blood pressure monitoring, which has gained traction due to increasing consumer health awareness. HillRom Holdings has expanded its product portfolio, focusing on the integration of cloud technologies for remote patient monitoring solutions. In terms of mergers and acquisitions, no recent deals have been reported involving major players in the market such as Roche Diagnostics, Takeda Pharmaceutical, or Medtronic, within the last three months.

    The market's growth has been further fueled by an increased emphasis on telehealth services, establishing a broad market valuation opportunity for companies like Abbott Laboratories and Baxter International. Moreover, Welch Allyn’s partnerships with healthcare providers aim to enhance the accessibility of testing devices, reflecting a broader trend towards improved healthcare delivery models. Over the past couple of years, particularly from January 2021 to October 2023, the market has undergone transformation influenced by regulatory support for electronic health records and the push for integrated health solutions across the United States.

    Market Segmentation

    Blood Pressure Test Market Product Outlook

    • sphygmomanometers
    • blood pressure transducers
    • instrument accessories

    Blood Pressure Test Market End User Outlook

    • hospital
    • clinic
    • diagnostic center

    Blood Pressure Test Market Indication Outlook

    • hypertension
    • coronary heart disease

    Report Scope

    Report Attribute/Metric Source: Details
    MARKET SIZE 2018 378.0(USD Million)
    MARKET SIZE 2024 480.0(USD Million)
    MARKET SIZE 2035 1170.0(USD Million)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 8.437% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Million
    KEY COMPANIES PROFILED Omron Healthcare, HillRom Holdings, Roche Diagnostics, Takeda Pharmaceutical, Medtronic, Abbott Laboratories, Baxter International, Welch Allyn, Microlife Corporation, A and D Medical, Cardinal Health, GE Healthcare, Philips Healthcare
    SEGMENTS COVERED Product, Indication, End User
    KEY MARKET OPPORTUNITIES Telehealth integration for remote monitoring, Increasing home testing demand, Advanced wearable technology adoption, Aging population driving needs, Preventive health management initiatives
    KEY MARKET DYNAMICS Increasing hypertension prevalence, Technological advancements in devices, Growing health consciousness, Rising geriatric population, Favorable reimbursement policies
    COUNTRIES COVERED US

    FAQs

    What is the expected market size of the US Blood Pressure Test Market in 2024?

    The US Blood Pressure Test Market is expected to be valued at 480.0 million USD in 2024.

    What is the projected market size for the US Blood Pressure Test Market by 2035?

    By 2035, the US Blood Pressure Test Market is projected to reach a value of 1170.0 million USD.

    What is the expected compound annual growth rate (CAGR) for the US Blood Pressure Test Market from 2025 to 2035?

    The expected CAGR for the US Blood Pressure Test Market from 2025 to 2035 is 8.437%.

    What are the main product segments in the US Blood Pressure Test Market?

    The main product segments in the US Blood Pressure Test Market include sphygmomanometers, blood pressure transducers, and instrument accessories.

    How is the sphygmomanometers segment expected to perform by 2035?

    The sphygmomanometers segment is expected to be valued at 400.0 million USD by 2035.

    What is the expected market value for blood pressure transducers in 2024?

    The blood pressure transducers segment is expected to be valued at 150.0 million USD in 2024.

    How much is the instrument accessories segment projected to grow by 2035?

    The instrument accessories segment is projected to grow to 420.0 million USD by 2035.

    Who are the major players in the US Blood Pressure Test Market?

    Some major players in the US Blood Pressure Test Market include Omron Healthcare, HillRom Holdings, and Roche Diagnostics, among others.

    What are the growth drivers for the US Blood Pressure Test Market?

    Key growth drivers for the US Blood Pressure Test Market include an increasing prevalence of hypertension and a growing aging population.

    What challenges does the US Blood Pressure Test Market currently face?

    Challenges facing the US Blood Pressure Test Market include regulatory hurdles and competition among various manufacturers.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials